» Articles » PMID: 27900955

Serum Levels of N-terminal-pro B-type Natriuretic Peptide As a Diagnostic Marker for Left Ventricular Dysfunction in Children with End-stage Renal Disease on Hemodialysis

Overview
Date 2016 Dec 1
PMID 27900955
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to determine the diagnostic cutoff value of N-terminal-pro B-type natriuretic peptide (NT-pro BNP) as a marker of left ventricular (LV) dysfunction in children with end-stage renal disease (ESRD) on regular hemodialysis (HD). The study was carried out on thirty children with ESRD on regular HD and thirty healthy controls. Echocardiographic studies were done, including a conventional mode for ejection fraction, fractional shortening, tissue Doppler imaging, and longitudinal global strain by speckle tracking. Serum levels of NT-pro BNP were measured in venous blood samples before and about 30 min after HD by ELISA. Volume status was assessed by calculating interdialytic weight gain %. There were significant higher serum NT-pro BNP levels before HD (mean: 702.3 ± 274.3 ng/L) compared to controls (mean: 365.55 ± 76.5 ng/L) (P <0.001) and these levels decreased significantly after the HD session (mean: 625.1 ± 117.69 ng/L) (P = 0.031). Echocardiographic studies showed a significant impairment of LV function of the patients compared to controls. Patients with LV dysfunction had significant higher serum concentrations of NT-pro BNP compared to patients without dysfunction both before (P = 0.003) and after dialysis (P <0.001). Receiver operating curve demonstrated better prediction of LV dysfunction by NT-pro BNP levels after HD compared to its levels before HD (area under the curve was 0.9 and 0.73, respectively). Using a cutoff value of 630 ng/L, serum NT-pro BNP levels after dialysis were a diagnostic predictor of LV dysfunction with a sensitivity of 86.6%, specificity of 93.3%, positive predictive value of 92.8%, and negative predictive value of 87.5%. Serum NT-pro BNP levels were strongly correlated with the parameters of LV dysfunction in children with ESRD on regular HD. A postdialysis cutoff value of 630 ng/L could serve as a biochemical marker of LV dysfunction in those children regardless of chronic fluid overload.

Citing Articles

Heart failure biomarkers in hemodialysis patients.

Heleniak Z, Bohdan M, Gruchala M, Debska-Slizien A Cardiol J. 2024; 31(4):628-636.

PMID: 38994825 PMC: 11374321. DOI: 10.5603/cj.92167.


NT-proBNP point-of-care testing for predicting mortality in end-stage renal disease: A survival analysis.

Chen C, Hsu Y, Chou K, Chang K, Hsu Y, Chiu W Heliyon. 2024; 10(9):e30581.

PMID: 38742053 PMC: 11089362. DOI: 10.1016/j.heliyon.2024.e30581.


Assessment of fluid status in neonatal dialysis: the need for new tools.

Nourbakhsh N, Benador N Pediatr Nephrol. 2022; 38(4):1373-1379.

PMID: 36459242 PMC: 9925496. DOI: 10.1007/s00467-022-05829-2.


Plasma Brain Natriuretic Peptide Levels in Children with Chronic Kidney Disease and Renal Transplant Recipients: A Single Center Study.

Garoufi A, Koumparelou A, Askiti V, Lykoudis P, Mitsioni A, Drapanioti S Children (Basel). 2022; 9(6).

PMID: 35740855 PMC: 9222167. DOI: 10.3390/children9060916.


Prognostic impact of albumin-bilirubin score on the prediction of in-hospital mortality in patients with heart failure: a retrospective cohort study.

Han S, Wang C, Tong F, Li Y, Li Z, Sun Z BMJ Open. 2022; 12(1):e049325.

PMID: 34983753 PMC: 8728421. DOI: 10.1136/bmjopen-2021-049325.